Hospital-Acquired Infection Diagnostics Market Growth Opportunities, Challenges, Investment Opportunities

The HAI diagnostics market size is projected to cross $4.3 billion by 2023, growing at a CAGR of 7.6% between 2017-2023. The growth in the market will be led by the increase in incidences of infections caused in clinical settings, especially in developing economies owing to their poor hygiene facilities.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market

In terms of product, the HAI diagnostics market is segmented into reagents & consumables and instruments. The reagents & consumables occupied the larger share in the market in 2016 and are expected to maintain the same trend throughout the forecast period. This is attributable to specificity of the reagents providing the accurate results with the target substance in the sample. In medical laboratories, reagents play an important role in diagnostic testing assays of infectious diseases.

In terms of application, the HAI diagnostics market is segmented into drug-resistance testing and disease testing. The drug-resistance testing held the larger share in the market in 2016, owing to the modernization in molecular diagnostics that has enabled drug-resistance testing. With the development of novel testing techniques such as phenotypic resistance testing, hybridization methods, sample processing and sequencing the diagnosis rate has increased to may folds and is expected to grow in near future.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hospital-acquired-infection-diagnostics-market/report-sample

The European HAI diagnostics market is projected to grow at a steady pace during 2017-2023, to cross $1.2 billion by 2023. According to the International Trade Administration (ITA), there is growth in the market, with the major companies such as Roche Diagnostics Limited, Abbott Laboratories, and others investing more in the R&D of the innovative diagnostics products to remain competitive in this field. Along with it, the growth of the hospital acquired diagnostics market in Europe is also characterized by the increase in geriatric population and high incidence of hospital acquired infections.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hospital-acquired-infection-diagnostics-market

Some of the key players operating in the HAI diagnostics market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Daiichi Sankyo Co. Ltd., Danaher Corporation, Hologic Inc., Johnson & Johnson, OpGen Inc., and F. Hoffmann-La Roche AG.

About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:

P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.